ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 原著論文

Metabolic characterization of aggressive breast cancer cells exhibiting invasive phenotype: impact of non-cytotoxic doses of 2-DG on diminishing invasiveness

https://repo.qst.go.jp/records/80803
https://repo.qst.go.jp/records/80803
443bb979-5c04-4075-ab87-0adb02ffe6dd
Item type 学術雑誌論文 / Journal Article(1)
公開日 2020-10-07
タイトル
タイトル Metabolic characterization of aggressive breast cancer cells exhibiting invasive phenotype: impact of non-cytotoxic doses of 2-DG on diminishing invasiveness
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
アクセス権
アクセス権 metadata only access
アクセス権URI http://purl.org/coar/access_right/c_14cb
著者 Fujita, Mayumi

× Fujita, Mayumi

WEKO 1011953

Fujita, Mayumi

Search repository
Imadome, Kaori

× Imadome, Kaori

WEKO 1011954

Imadome, Kaori

Search repository
Somasundaram, Veena

× Somasundaram, Veena

WEKO 1011955

Somasundaram, Veena

Search repository
Kawanishi, Miki

× Kawanishi, Miki

WEKO 1011956

Kawanishi, Miki

Search repository
Karasawa, Kumiko

× Karasawa, Kumiko

WEKO 1011957

Karasawa, Kumiko

Search repository
A Wink, David

× A Wink, David

WEKO 1011958

A Wink, David

Search repository
Mayumi, Fujita

× Mayumi, Fujita

WEKO 1011959

en Mayumi, Fujita

Search repository
Kaori, Imadome

× Kaori, Imadome

WEKO 1011960

en Kaori, Imadome

Search repository
抄録
内容記述タイプ Abstract
内容記述 Background: Metabolic reprogramming is being recognized as a fundamental hallmark of cancer, and efforts to identify drugs that can target cancer metabolism are underway. In this study, we used human breast cancer (BC) cell lines and established their invading phenotype (INV) collected from transwell inserts to compare metabolome differences and evaluate prognostic significance of the metabolome in aggressive BC invasiveness.

Methods: The invasiveness of seven human BC cell lines were compared using the transwell invasion assay. Among these, INV was collected from SUM149, which exhibited the highest invasiveness. Levels of metabolites in INV were compared with those of whole cultured SUM149 cells (WCC) using CE-TOFMS. The impact of glycolysis in INV was determined by glucose uptake assay using fluorescent derivative of glucose (2-NBDG), and significance of glycolysis, or tricarboxylic acid cycle (TCA) and electron transport chain (ETC) in the invasive process were further
determined in aggressive BC cell lines, SUM149, MDA-MB-231, HCC1937, using invasion assays in the presence or absence of inhibitors of glycolysis, TCA cycle or ETC.

Results: SUM149 INV sub-population exhibited a persistent hyperinvasive phenotype. INV were hyper-glycolytic with increased glucose (2-NBDG) uptake; diminished glucose-6-phosphate (G6P) levels but elevated pyruvate and lactate, along with higher expression of phosphorylated-pyruvate dehydrogenase (pPDH) compared to WCC. Notably, inhibiting of glycolysis with lower doses of 2-DG (1 mM), non-cytotoxic to MDA-MB-231 and HCC1937, was effective in diminishing invasiveness of aggressive BC cell lines. In contrast, 3-Nitropropionic acid (3-NA), an inhibitor of succinate dehydrogenase, the enzyme that oxidizes succinate to fumarate in TCA cycle, and functions as complex II of ETC, had no significant effect on their invasiveness, although levels of TCA metabolites or detection of
mitochondrial membrane potential with JC-1 staining, indicated that INV cells originally had functional TCA cycles and membrane potential.

Conclusions: Hyper-glycolytic phenotype of invading cells caters to rapid energy production required for invasion while TCA cycle/ETC cater to cellular energy needs for sustenance in aggressive BC. Lower, non-cytotoxic doses of 2-DG can hamper invasion and can potentially be used as an adjuvant with other anti-cancer therapies without the usual side-effects associated with cytotoxic doses.
書誌情報 BMC Cancer

巻 20, 号 1, p. 929, 発行日 2020-09
出版者
出版者 BioMed Central
ISSN
収録物識別子タイプ ISSN
収録物識別子 1471-2407
PubMed番号
識別子タイプ PMID
関連識別子 32993545
DOI
識別子タイプ DOI
関連識別子 10.1186/s12885-020-07414-y
関連サイト
識別子タイプ URI
関連識別子 https://bmccancer.biomedcentral.com/articles/10.1186/s12885-020-07414-y
戻る
0
views
See details
Views

Versions

Ver.1 2023-05-15 17:19:39.959098
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3